DOI QR코드

DOI QR Code

The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: A review

  • Klay Puay Khim Lim (Lee Kong Chian School of Medicine, Nanyang Technological University) ;
  • Aaron Jia Loong Lee (Lee Kong Chian School of Medicine, Nanyang Technological University) ;
  • Xiuting Jiang (Lee Kong Chian School of Medicine, Nanyang Technological University) ;
  • Thomas Zheng Jie Teng (Lee Kong Chian School of Medicine, Nanyang Technological University) ;
  • Vishal G. Shelat (Department of General Surgery, Tan Tock Seng Hospital)
  • Received : 2022.07.25
  • Accepted : 2023.03.08
  • Published : 2023.08.31

Abstract

Helicobacter pylori is a gram-negative pathogen commonly associated with peptic ulcer disease and gastric cancer. H. pylori infection has also been reported in cholelithiasis, cholecystitis, gallbladder polyps, and biliary tract cancers. However, the association between H. pylori and gallbladder and biliary tract pathologies remains unclear due to the paucity of literature. In response to the current literature gap, we aim to review and provide an updated summary of the association between H. pylori with gallbladder and biliary tract diseases and its impact on their clinical management. Relevant peer-reviewed studies were retrieved from Medline, PubMed, Embase, and Cochrane databases. We found that H. pylori infection was associated with cholelithiasis, chronic cholecystitis, biliary tract cancer, primary sclerosing cholangitis, and primary biliary cholangitis but not with gallbladder polyps. While causal links have been reported, prospective longitudinal studies are required to conclude the association between H. pylori and gallbladder pathologies. Clinicians should be aware of the implications that H. pylori infection has on the management of these diseases.

Keywords

References

  1. Lehours P. Actual diagnosis of Helicobacter pylori infection. Minerva Gastroenterol Dietol 2018;64:267-279. https://doi.org/10.23736/S1121-421X.18.02494-7
  2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131. https://doi.org/10.1056/NEJM199110173251603
  3. Veldhuyzen van Zanten SJ, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ 1994;150:177-185.
  4. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-1271. https://doi.org/10.1056/NEJM199405053301803
  5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789. https://doi.org/10.1056/NEJMoa001999
  6. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A 2009;106:14321-14326. https://doi.org/10.1073/pnas.0903438106
  7. Popescu D, Andronescu D, Babes PA. The association between Helicobacter pylori infection and liver and biliary tract disorders. Curr Health Sci J 2018;44:186-191.
  8. Xu MY, Ma JH, Yuan BS, Yin J, Liu L, Lu QB. Association between Helicobacter pylori infection and gallbladder diseases: a retrospective study. J Gastroenterol Hepatol 2018;33:1207-1212. https://doi.org/10.1111/jgh.14054
  9. Aviles-Jimenez F, Guitron A, Segura-Lopez F, Mendez-Tenorio A, Iwai S, Hernandez-Guerrero A, et al. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clin Microbiol Infect 2016;22:178.e11-178.e22. https://doi.org/10.1016/j.cmi.2015.09.007
  10. Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C, et al. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford) 2012;14:177-184. https://doi.org/10.1111/j.1477-2574.2011.00423.x
  11. Fallone CA, Tran S, Semret M, Discepola F, Behr M, Barkun AN. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment Pharmacol Ther 2003;17:453-458. https://doi.org/10.1046/j.1365-2036.2003.01424.x
  12. Patnayak R, Reddy V, Jena A, Gavini S, Thota A, Nandyala R, et al. Helicobacter pylori in cholecystectomy specimens-morphological and immunohistochemical assessment. J Clin Diagn Res 2016;10:EC01-EC03. https://doi.org/10.7860/JCDR/2016/14802.7716
  13. Waluga M, Kukla M, Zorniak M, Bacik A, Kotulski R. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 2015;7:2136-2146. https://doi.org/10.4254/wjh.v7.i18.2136
  14. Helaly GF, El-Ghazzawi EF, Kazem AH, Dowidar NL, Anwar MM, Attia NM. Detection of Helicobacter pylori infection in Egyptian patients with chronic calcular cholecystitis. Br J Biomed Sci 2014;71:13-18. https://doi.org/10.1080/09674845.2014.11669957
  15. Caldwell MT, McDermott M, Jazrawi S, O'Dowd G, Byrne PJ, Walsh TN, et al. Helicobacter pylori infection increases following cholecystectomy. Ir J Med Sci 1995;164:52-55. https://doi.org/10.1007/BF02968117
  16. Magnuson TH, Lillemoe KD, Zarkin BA, Pitt HA. Patients with uncomplicated cholelithiasis acidify bile normally. Dig Dis Sci 1992;37:1517-1522. https://doi.org/10.1007/BF01296496
  17. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol 2014;20:12847-12859. https://doi.org/10.3748/wjg.v20.i36.12847
  18. Clayton C, Kleanthous K, Tabaqchali S. Detection and identification of Helicobacter pylori by the polymerase chain reaction. J Clin Pathol 1991;44:515-516. https://doi.org/10.1136/jcp.44.6.515
  19. De Reuse H, Labigne A, Mengin-Lecreulx D. The Helicobacter pylori ureC gene codes for a phosphoglucosamine mutase. J Bacteriol 1997;179:3488-3493. https://doi.org/10.1128/jb.179.11.3488-3493.1997
  20. Lee JW, Lee DH, Lee JI, Jeong S, Kwon KS, Kim HG, et al. Identification of Helicobacter pylori in gallstone, bile, and other hepatobiliary tissues of patients with cholecystitis. Gut Liver 2010;4:60-67. https://doi.org/10.5009/gnl.2010.4.1.60
  21. Singh V, Mishra S, Rao GR, Jain AK, Dixit VK, Gulati AK, et al. Evaluation of nested PCR in detection of Helicobacter pylori targeting a highly conserved gene: HSP60. Helicobacter 2008;13:30-34. https://doi.org/10.1111/j.1523-5378.2008.00573.x
  22. Mishra RR, Tewari M, Shukla HS. Helicobacter pylori and pathogenesis of gallbladder cancer. J Gastroenterol Hepatol 2011;26:260-266. https://doi.org/10.1111/j.1440-1746.2010.06435.x
  23. Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med 2015;3:10.
  24. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992;30:192-200. https://doi.org/10.1128/jcm.30.1.192-200.1992
  25. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000;38:1072-1076. https://doi.org/10.1128/JCM.38.3.1072-1076.2000
  26. Yu G, Fadrosh D, Goedert JJ, Ravel J, Goldstein AM. Nested PCR biases in interpreting microbial community structure in 16S rRNA gene sequence datasets. PLoS One 2015;10:e0132253.
  27. Sugimoto M, Wu JY, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, et al. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol 2009;47:738-742. https://doi.org/10.1128/JCM.01563-08
  28. Sulo P, Sipkova B. DNA diagnostics for reliable and universal identification of Helicobacter pylori. World J Gastroenterol 2021;27:7100-7112. https://doi.org/10.3748/wjg.v27.i41.7100
  29. Seligova B, Lukac L, Babelova M, Vavrova S, Sulo P. Diagnostic reliability of nested PCR depends on the primer design and threshold abundance of Helicobacter pylori in biopsy, stool, and saliva samples. Helicobacter 2020;25:e12680.
  30. Leong RW, Sung JJ. Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 2002;16:1037-1045. https://doi.org/10.1046/j.1365-2036.2002.01282.x
  31. Shimoyama T, Takahashi R, Abe D, Mizuki I, Endo T, Fukuda S. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010;25 Suppl 1:S86-S89. https://doi.org/10.1111/j.1440-1746.2010.06224.x
  32. On SL. Identification methods for campylobacters, helicobacters, and related organisms. Clin Microbiol Rev 1996;9:405-422. https://doi.org/10.1128/CMR.9.3.405
  33. Shukla HS, Tewari M. Discovery of Helicobacter pylori in gallbladder. Indian J Gastroenterol 2012;31:55-56. https://doi.org/10.1007/s12664-012-0178-0
  34. Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol 2000;53:756-759. https://doi.org/10.1136/jcp.53.10.756
  35. Chen W, Li D, Cannan RJ, Stubbs RS. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis 2003;35:237-243. https://doi.org/10.1016/S1590-8658(03)00060-4
  36. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998;114:755-763. https://doi.org/10.1016/S0016-5085(98)70589-X
  37. Bostanoglu E, Karahan ZC, Bostanoglu A, Savas B, Erden E, Kiyan M. Evaluation of the presence of Helicobacter species in the biliary system of Turkish patients with cholelithiasis. Turk J Gastroenterol 2010;21:421-427. https://doi.org/10.4318/tjg.2010.0130
  38. Grigor'eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms 2020;8:835.
  39. Zhou D, Guan WB, Wang JD, Zhang Y, Gong W, Quan ZW. A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa. PLoS One 2013;8:e70265.
  40. Abayli B, Colakoglu S, Serin M, Erdogan S, Isiksal YF, Tuncer I, et al. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol 2005;39:134-137.
  41. Pellicano R, Menard A, Rizzetto M, Megraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8:254-260. https://doi.org/10.1016/S1473-3099(08)70066-5
  42. Mohan R, Wei Lynn Goh S, Tan GW, Tan YP, Junnarkar SP, Huey CWT, et al. Validation of Tokyo Guidelines 2007 and Tokyo Guidelines 2013/2018 criteria for acute cholangitis and predictors of in-hospital mortality. Visc Med 2021;37:434-442. https://doi.org/10.1159/000516424
  43. Wang L, Chen J, Jiang W, Cen L, Pan J, Yu C, et al. The relationship between Helicobacter pylori infection of the gallbladder and chronic cholecystitis and cholelithiasis: a systematic review and meta-analysis. Can J Gastroenterol Hepatol 2021;2021:8886085.
  44. Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, Wang X, et al. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One 2011;6:e27390.
  45. Zhang FM, Yu CH, Chen HT, Shen Z, Hu FL, Yuan XP, et al. Helicobacter pylori infection is associated with gallstones: epidemiological survey in China. World J Gastroenterol 2015;21:8912-8919. https://doi.org/10.3748/wjg.v21.i29.8912
  46. Takahashi Y, Yamamichi N, Shimamoto T, Mochizuki S, Fujishiro M, Takeuchi C, et al. Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan. J Gastroenterol 2014;49:882-889. https://doi.org/10.1007/s00535-013-0832-z
  47. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017;153:420-429. https://doi.org/10.1053/j.gastro.2017.04.022
  48. Cen L, Pan J, Zhou B, Yu C, Li Y, Chen W, et al. Helicobacter pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: a systematic review and meta-analysis. Helicobacter 2018;23:e12457.
  49. Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg 2010;126:2234-2242. https://doi.org/10.1097/PRS.0b013e3181f44abc
  50. Zhang J, Zhang Y, Chen Y, Chen W, Xu H, Sun W. Helicobacter pylori is not a contributing factor in gallbladder polyps or gallstones: a case-control matching study of Chinese individuals. J Int Med Res 2020;48:300060520959220.
  51. Andren-Sandberg A. Diagnosis and management of gallbladder polyps. N Am J Med Sci 2012;4:203-211. https://doi.org/10.4103/1947-2714.95897
  52. Kim KH. Gallbladder polyps: evolving approach to the diagnosis and management. Yeungnam Univ J Med 2021;38:1-9. https://doi.org/10.12701/yujm.2020.00213
  53. Park JY, Hong SP, Kim YJ, Kim HJ, Kim HM, Cho JH, et al. Longterm follow up of gallbladder polyps. J Gastroenterol Hepatol 2009;24:219-222. https://doi.org/10.1111/j.1440-1746.2008.05689.x
  54. Cairns V, Neal CP, Dennison AR, Garcea G. Risk and cost-effectiveness of surveillance followed by cholecystectomy for gallbladder polyps. Arch Surg 2012;147:1078-1083. https://doi.org/10.1001/archsurg.2012.1948
  55. Hassan EH, Gerges SS, El-Atrebi KA, El-Bassyouni HT. The role of H. pylori infection in gall bladder cancer: clinicopathological study. Tumour Biol 2015;36:7093-7098. https://doi.org/10.1007/s13277-015-3444-9
  56. Chang JS, Tsai CR, Chen LT. Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study. PLoS One 2013;8:e69981.
  57. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980;45:919-927.
  58. Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder cancer: an update. Mutat Res 2019;816-818:111674.
  59. Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer 2019;19:185.
  60. Wang Y, Imran A, Shami A, Chaudhary AA, Khan S. Decipher the Helicobacter pylori protein targeting in the nucleus of host cell and their implications in gallbladder cancer: an insilico approach. J Cancer 2021;12:7214-7222. https://doi.org/10.7150/jca.63517
  61. Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book 2016;35:e194-e203. https://doi.org/10.14694/EDBK_160831
  62. Ghidini M, Tomasello G, Botticelli A, Barni S, Zabbialini G, Seghezzi S, et al. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis. HPB (Oxford) 2017;19:741-748. https://doi.org/10.1016/j.hpb.2017.05.010
  63. Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol 2019;37:1015-1027. https://doi.org/10.1200/JCO.18.02178
  64. Chew CA, Lye TF, Ang D, Ang TL. The diagnosis and management of H. pylori infection in Singapore. Singapore Med J 2017;58:234-240. https://doi.org/10.11622/smedj.2017037
  65. Bansal VK, Misra MC, Chaubal G, Datta Gupta S, Das B, Ahuja V, et al. Helicobacter pylori in gallbladder mucosa in patients with gallbladder disease. Indian J Gastroenterol 2012;31:57-60. https://doi.org/10.1007/s12664-012-0162-8
  66. Terjung B, Spengler U. Atypical p-ANCA in PSC and AIH: a hint to-ward a "leaky gut"? Clin Rev Allergy Immunol 2009;36:40-51. https://doi.org/10.1007/s12016-008-8088-8
  67. Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis 2020;40:34-48. https://doi.org/10.1055/s-0039-1697617
  68. Boomkens SY, de Rave S, Pot RG, Egberink HF, Penning LC, Rothuizen J, et al. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis. FEMS Immunol Med Microbiol 2005;44:221-225. https://doi.org/10.1016/j.femsim.2004.11.002
  69. Wang J, Chen RC, Zheng YX, Zhao SS, Li N, Zhou RR, et al. Helicobacter pylori infection may increase the risk of progression of chronic hepatitis B disease among the Chinese population: a meta-analysis. Int J Infect Dis 2016;50:30-37. https://doi.org/10.1016/j.ijid.2016.07.014
  70. Marchioni Beery RM, Vaziri H, Forouhar F. Primary biliary cirrhosis and primary sclerosing cholangitis: a review featuring a women's health perspective. J Clin Transl Hepatol 2014;2:266-284. Erratum in: J Clin Transl Hepatol 2015;3:162.
  71. Eslami B, Iranshahi M, Gachkar L , Hadavand F. Gallstone frequency in patients with Helicobacter pylori gastritis. Arch Clin Infect Dis 2021;16:e100805.
  72. Kucuk S, Kucuk IG. The relationship between Helicobacter pylori and gallbladder pathologies, dysplasia and gallbladder cancer. Acta Med Mediterr 2021;37:2613-2620.
  73. Mahmood A, Khan Z, Razzaq S, Mahmood MA, Ahmed N, Iqbal W. The likelihood of Helicobacter pylori presence in pre cholecystectomy gall bladder with or without cholecystitis - a case control study. Pak J Med Health Sci 2020;14:304-306.
  74. Makkar R, Butt J, Huang WY, McGlynn KA, Koshiol J, Pawlita M, et al. Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study. Br J Cancer 2020;123:909-911. https://doi.org/10.1038/s41416-020-0961-0
  75. Kerawala A, Bakhtiar N, Abidi S, Awan S. Association of gallstone and Helicobacter pylori. J Med Sci 2019;27:269-272.
  76. Ari A, Tatar C, Yarikkaya E. Relationship between Helicobacter pylori-positivity in the gallbladder and stomach and effect on gallbladder pathologies. J Int Med Res 2019;47:4904-4910. https://doi.org/10.1177/0300060519847345
  77. Cherif S, Rais H, Hakmaoui A, Sellami S, Elantri S, Amine A. Linking Helicobacter pylori with gallbladder and biliary tract cancer in Moroccan population using clinical and pathological profiles. Bioinformation 2019;15:735-743. https://doi.org/10.6026/97320630015735
  78. Fatemi SM, Doosti A, Shokri D, Ghorbani-Dalini S, Molazadeh M, Tavakoli H, et al. Is there a correlation between Helicobacter pylori and enterohepatic helicobacter species and gallstone cholecystitis? Middle East J Dig Dis 2018;10:24-30. https://doi.org/10.15171/mejdd.2017.86
  79. Dar MY, Ali S, Raina AH, Raina MA, Shah OJ, Shah MA, et al. Association of Helicobacter pylori with hepatobiliary stone disease, a prospective case control study. Indian J Gastroenterol 2016;35:343-346. https://doi.org/10.1007/s12664-016-0675-7
  80. Guraya SY, Ahmad AA, El-Ageery SM, Hemeg HA, Ozbak HA, Yousef K, et al. The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia. Eur Rev Med Pharmacol Sci 2015;19:3873-3880.
  81. Attaallah W, Yener N, Ugurlu MU, Manukyan M, Asmaz E, Aktan AO. Gallstones and concomitant gastric Helicobacter pylori infection. Gastroenterol Res Pract 2013;2013:643109.
  82. Abro AH, Haider IZ, Ahmad S. Helicobacter pylori infection in patients with calcular cholecystitis: a hospital based study. J Ayub Med Coll Abbottabad 2011;23:30-33.
  83. Yakoob J, Khan MR, Abbas Z, Jafri W, Azmi R, Ahmad Z, et al. Helicobacter pylori: association with gall bladder disorders in Pakistan. Br J Biomed Sci 2011;68:59-64. https://doi.org/10.1080/09674845.2011.11730324
  84. Chen DF, Hu L, Yi P, Liu WW, Fang DC, Cao H. H pylori exist in the gallbladder mucosa of patients with chronic cholecystitis. World J Gastroenterol 2007;13:1608-1611. https://doi.org/10.3748/wjg.v13.i10.1608
  85. Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL, Sarmanho L, et al. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 2003;41:5615-5618. https://doi.org/10.1128/JCM.41.12.5615-5618.2003
  86. Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and long-term safety of H. pylori eradication for gastric cancer prevention. Cancers (Basel) 2019;11:593.
  87. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence consensus report. Gut 2012;61:646-664. https://doi.org/10.1136/gutjnl-2012-302084
  88. Teng TZJ, Sudharsan M, Yau JWK, Tan W, Shelat VG. Helicobacter pylori knowledge and perception among multi-ethnic Asians. Helicobacter 2021;26:e12794.
  89. Chua BQY, Chong VWS, Teng TZJ, Chia CTW, Aung MO, Shelat VG. Does technology-enhanced communication improve Helicobacter pylori eradication outcomes?-A meta-analysis. Helicobacter 2022;27:e12890.